Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지

Patterns of Over-the-Counter Drug Use and Interactions between Over-the-Counter Drugs and Prescription Drugs in Adults Visiting a Community Pharmacy

지역약국 방문 성인의 일반의약품 복용실태 및 일반의약품과 처방의약품과의 상호작용 연구

  • Chae, Min Kyoung (Medical Information Team, JW Pharmaceutical Co., Ltd.) ;
  • Bang, Joon Seok (Department of Clinical pharmacy, College of Pharmacy, Chosun University) ;
  • Lee, Yu Jeung (Department of Clinical Pharmacy, College of Pharmacy, Kangwon National University)
  • Received : 2013.01.24
  • Accepted : 2013.03.07
  • Published : 2013.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: The purpose of this study was to evaluate the patterns of Over-the-Counter (OTC) drugs and their interactions with prescription drugs in adults visiting a community pharmacy. Method: The subjects were 151 adults aged over 20 years visiting a community pharmacy in Asan-si from December 16th 2011 to February 1st 2012. We used a survey questionnaire. The survey inquired about the prevalence and the details of any OTC drug use and the characteristics of the study subjects. The drug interaction classification system from Lexicomp's Lexi-interact data fields was used to identify OTC drugs likely to have clinically significant interactions with prescription drugs. Results: The patterns of OTC drug use were related to thirties (from 30 to 40 years old), female gender, higher education, non-smoking, sometimes use of alcohol, and self-perceived normal health status. The most commonly used OTC drug category was antipyretic-analgesics (n=104, 53.3%), and the most commonly used ingredient was acetaminophen (n=67, 64.4%). The biggest motivation for taking OTC drugs was suggestion by pharmacists, reported by 55.6%. After reviewing each patient's prescription drugs and OTC drugs, 14 patients (36.8%) of 38 patients using prescription drugs were taking drug combinations with potential for clinically significant interactions. The concomitant use of OTC drugs with prescription drugs may lead to increased potentially harmful interactions. Conclusion: It is suggested that health-care professionals should be more aware of the potential and possible interactions and take into better account their patients' OTC drug use.

Keywords

References

  1. Brass EP. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med 2001; 345: 810-6. https://doi.org/10.1056/NEJMra011080
  2. 백병성. 단순의약품(OTC) 판매. 한국법제연구원 2011.
  3. 대한약사회시흥분회. 일반소비자의 일반의약품 지식습득 실태 및 부작용 경험사례 분석. 의약정보. 약업신문. 2007.
  4. 김경례. 의약품 부작용 실태조사. 한국소비자원. 2008.
  5. Morgan PP, Cohen L. Off the prescription pad and over the counter: the trend toward drug deregulation grows. CMAJ 1995; 152: 387-9.
  6. Honig PK, Gillespie BK. Drug interactions between prescribed and over-the-counter medication. Drug Saf 1995; 13: 296-303. https://doi.org/10.2165/00002018-199513050-00003
  7. Honig PK, Gillespie BK. Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs. Clin Pharmacokinet 1998; 35: 167-71. https://doi.org/10.2165/00003088-199835030-00001
  8. Sihvo S, Klaukka T, Martikainen J, et al., Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population. Eur J Clin Pharmacol 2000; 56: 495-9. https://doi.org/10.1007/s002280000145
  9. Holden MD. Over-the-counter medications. Do you know what your patients are taking? Postgrad Med 1992; 91: 191-194, 199-200.
  10. Lexicomp. Lexi-comp Inc Web site. http://www.lexi.com.
  11. Druginfo. http://www.druginfo.co.kr.
  12. 의약품등 분류번호에 관한 규정. 식품의약품안전청 예규 제 237호.
  13. 김재영, 백병성, OTC 의약품 판매제도의 문제점과 개선방안. 한국소비자원, 2010.
  14. 의약품조사관리시스템, http://pharm.mw.go.kr/. 보건복지부.
  15. Richardson T, Foster J, Mawer GE. Enhancement by sodium salicylate of the blood glucose lowering effect of chlorpropamide-drug interaction or summation of similar effects? Br J Clin Pharmacol 1986; 22: 43-8. https://doi.org/10.1111/j.1365-2125.1986.tb02878.x
  16. Kubacka RT, Antal EJ, Juhl RP, et al., Effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects. Ann Pharmacother 1996; 30: 20-6.
  17. Minuz P, Pancera P, Ribul M, et al., Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition. Br J Clin Pharmacol 1995; 39: 45-50. https://doi.org/10.1111/j.1365-2125.1995.tb04408.x
  18. Bomford J. Ciprofloxacin. Pharm J 1995; 255: 674.
  19. Takeo G, Shibuya N., Motomura M, el al., A new DNA gyrase inhibitor induces convulsions:A case report and animal experiments. Chemotherapy(Tokyo) 1989; 37: 1154-9.
  20. Morita H, Maemura K, Sakai Y, et al., A case of convulsion, loss of consciousness and subsequent acute renal failure caused by enoxacin and fenbufen. Nihon Naika Gakkai Zasshi 1988; 77: 744-5. https://doi.org/10.2169/naika.77.744
  21. Mizuno J, Sugimoto S, Kaneko A, et al., Convulsion following the combination of single preoperative oral administration of enoxacine and single postoperative intravenous administration of flurbiprofen axetil. Masui 2001; 50: 425-8.
  22. Kim J, Ohtani H, Tsujimoto M, et al., Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents. Drug Metab Pharmacokinet 2009; 24: 167-74. https://doi.org/10.2133/dmpk.24.167
  23. Rossi M, Giorgi G. Domperidone and long QT syndrome. Curr Drug Saf 2010; 5: 257-62. https://doi.org/10.2174/157488610791698334
  24. Ellershaw JE, Kelly MJ. Corticosteroids and peptic ulceration. Palliat Med 1994; 8: 313-9. https://doi.org/10.1177/026921639400800407
  25. Pecora, PG, Kaplan B. Corticosteroids and ulcers: is there an association? Ann Pharmacother 1996; 30: 870-2.
  26. Harris CL, Raisch DW, Abhyankar U, et al., GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs. Ann Pharmacother 2006; 40: 1924-31. https://doi.org/10.1345/aph.1H183
  27. Pentel P. Toxicity of over-the-counter stimulants. JAMA 1984; 252: 1898-1903. https://doi.org/10.1001/jama.1984.03350140044023
  28. Haller CA, Jacob P 3rd, Benowitz NL. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther 2002; 71: 421-32. https://doi.org/10.1067/mcp.2002.124523
  29. Tormey WP, Bruzzi A. Acute psychosis due to the interaction of legal compounds--ephedra alkaloids in 'vigueur fit' tablets, caffeine in 'red bull' and alcohol. Med Sci Law 2001; 41: 331-6.
  30. Mitchell JL. Use of cough and cold preparations during breastfeeding. J Hum Lact 1999; 15: 347-9. https://doi.org/10.1177/089033449901500417
  31. Cheung B, Nakashima AM, Hofer K. Various anti-motion sickness drugs and core body temperature changes. Aviat Space Environ Med 2011; 82: 409-15. https://doi.org/10.3357/ASEM.2903.2011
  32. Skidgel R, Erdos E. Histamine, bradykinin, and their antagonists. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 2005. 11th ed.(Brunton L, Ed. McGraw-Hill, New York): 629-52.
  33. Karamanakos P.N. Intoxication with over-the-counter antitussive medication containing dihydrocodeine and chlorpheniramine causes generalized convulsion and mixed acidosis. Intern Med, 2008; 47: 1821. https://doi.org/10.2169/internalmedicine.47.1408
  34. 건강보험심사평가원. http://www.hira.or.kr/.
  35. Sclar D, Robison L, Skaer T. Pharmacy consultation and over-the-counter medication purchasing outcomes. Over-the- Counter Medication Intervention Project Team. J Clin Pharm Ther 1996; 21: 177-84. https://doi.org/10.1111/j.1365-2710.1996.tb00019.x
  36. 민영미, 설재웅, 오희철, 이은숙. 소비자와 약사들의 일반의 약품에 대한 인식 및 행태에 관한 연구. 약물역학위해관리학회지 2009; 2: 114-21.
  37. 염민선. 일반의약품 판매규제 완화효과와 정책제언. 유통연구 2010; 15: 237-55.